Endo Axiom
PrivateLast Round
Accelerator
Apr 18, 2023
Total Funding Raised
$1.47M
Momentum Score
25 /100
Company Overview
Endo Axiom is a biotechnology company developing platforms for the oral delivery of drugs and biologics, including an oral smart insulin and an immune modulation platform to prevent type one diabetes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Endo Axiom Comps
Public and private peers based on sector, stage, and business model.
Endo Axiom Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Apr 18, 2023 |
Endo Axiom Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Proto Axiom | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors increased 151% MoM, reaching 1.2K.
Endo Axiom Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Endo Axiom's valuation, stock price, and market status.
